United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Quest Diagnostics to add ctDNA detection technology with Haystack Oncology Quest Diagnostics, an American diagnostic information services provider, has agreed to acquire early-stage oncology company Haystack Oncology in… byPallavi MadhirajuApril 30, 2023